deltatrials
Active Not Recruiting NA INTERVENTIONAL 3-arm NCT02276443

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

ARTEMIS: A Robust TNBC Evaluation FraMework to Improve Survival

Sponsor: M.D. Anderson Cancer Center

Conditions Invasive Breast Carcinoma Stage I Breast Cancer AJCC v7 Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Triple-Negative Breast Carcinoma
Interventions Chemotherapy Immunotherapy Laboratory Biomarker Analysis Lymph Node Biopsy Ultrasonography
Updated 18 times since 2017 Last updated: Jul 31, 2025 Started: Nov 9, 2015 Primary completion: Nov 30, 2026 Completion: Nov 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Invasive Breast Carcinoma and Stage I Breast Cancer AJCC v7, this trial is ongoing. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 18 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jun 2019 · 6 months · monthly snapshot~Jun 2019 – ~Feb 2020 · 8 months · monthly snapshot~Feb 2020 – ~Aug 2020 · 6 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~May 2021 · 3 months · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Jun 2022 · 12 months · monthly snapshot~Jun 2022 – ~Aug 2023 · 14 months · monthly snapshot~Aug 2023 – ~Feb 2024 · 6 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  2. Feb 2025 — Sep 2025 [monthly]

    Recruiting NA

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Feb 2024 — Jul 2024 [monthly]

    Recruiting NA

▶ Show 13 earlier versions

  1. Aug 2023 — Feb 2024 [monthly]

    Recruiting NA

  2. Jun 2022 — Aug 2023 [monthly]

    Recruiting NA

  3. Jun 2021 — Jun 2022 [monthly]

    Recruiting NA

  4. May 2021 — Jun 2021 [monthly]

    Recruiting NA

  5. Feb 2021 — May 2021 [monthly]

    Recruiting NA

  6. Jan 2021 — Feb 2021 [monthly]

    Recruiting NA

  7. Aug 2020 — Jan 2021 [monthly]

    Recruiting NA

  8. Feb 2020 — Aug 2020 [monthly]

    Recruiting NA

  9. Jun 2019 — Feb 2020 [monthly]

    Recruiting NA

  10. Dec 2018 — Jun 2019 [monthly]

    Recruiting NA

  11. Jun 2018 — Dec 2018 [monthly]

    Recruiting NA

  12. Dec 2017 — Jun 2018 [monthly]

    Recruiting NA

  13. Jan 2017 — Dec 2017 [monthly]

    Recruiting NA

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations